The Gamma Knife system is a highly precise, non-invasive radiosurgery device used to treat brain tumors, vascular malformations, and functional disorders. Leveraging focused gamma radiation beams, it delivers submillimeter accuracy without incisions, reducing patient recovery time and minimizing complications. Advantages include outpatient procedures, reduced hospital stays, and lower risk of infection compared to traditional neurosurgery. As the prevalence of brain disorders and oncology cases rises globally—driven by an aging population and improved diagnostic imaging—the need for advanced stereotactic radiosurgery solutions has never been greater. Healthcare providers are increasingly investing in cutting-edge devices to gain competitive market share and bolster business growth. Moreover, hospitals and specialty clinics seek robust market insights to optimize their equipment portfolios.
Global Gamma Knife Market is estimated to be valued at US$ 265.62 Bn in 2025 and is expected to exhibit a CAGR of 5.4% over the forecast period 2025 to 2032.
Key Takeaways
Key players operating in the Gamma Knife Market are Elekta, American Radiosurgery Inc., Masep Medical Science & Technology Development Co., Ltd., Panacea Medical Technologies Pvt. Ltd., and Nordion (Canada) Inc. These market companies dominate the competitive landscape by offering comprehensive service agreements, cutting-edge hardware upgrades, and strong after-sales support. Continuous R&D investment by these leaders fosters innovation in collimator design and radiation delivery, strengthening their market position and sustaining sizeable market share.
Gamma Knife Market Insights is growing demand for minimally invasive and outpatient neurosurgical procedures is a significant driver of market growth. Hospitals and cancer treatment centers worldwide are expanding their radiosurgery portfolios to meet patient preference for shorter hospital stays and faster recovery. Increasing insurance coverage and favorable reimbursement policies are further fueling adoption. Emerging economies are investing in healthcare infrastructure, driven by rising healthcare expenditure, which augments the overall market size and broadens market scope in Asia Pacific and Latin America.
Market Trends
One key trend is the convergence of stereotactic radiosurgery with advanced neuroimaging. Real-time MRI guidance and PET integration allow clinicians to visualize tumor physiology during treatment, improving targeting precision and sparing healthy tissue. This fusion of technologies is reshaping treatment workflows and driving market trends toward fully integrated radiosurgery suites.
Market Opportunities
A major opportunity lies in developing portable and cost-effective Gamma Knife variants tailored to mid-size hospitals and specialty clinics. Modular designs and lower upfront investment models can unlock underserved segments, boosting overall market revenue.
Strategic partnerships between technology providers and academic medical centers represent another growth avenue. Joint research initiatives and clinical trials can expedite regulatory approvals for new indications—such as functional disorders and pediatric applications—expanding the market scope. These collaborations also generate valuable market research and insights, shaping future product roadmaps.
Impact of COVID-19 on Gamma Knife Market Growth
Prior to the COVID-19 outbreak, the Gamma Knife market exhibited robust market growth driven by stable capital investments in neurosurgical suites and an increasing incidence of brain tumors. Market dynamics were characterized by predictable procedural volumes, clear reimbursement pathways, and steadily rising market revenue. When the pandemic struck, hospitals reallocated resources toward acute care for infectious disease, creating significant market challenges. Elective and nonurgent radiosurgery procedures were deferred, disrupting the normal treatment pipeline. Strict travel restrictions and lockdowns hindered international training programs and slowed the global supply chain for critical components, generating market restraints in several regions.
Geographical Concentration of Gamma Knife Market Value
North America remains the largest regional contributor to Gamma Knife market revenue, accounting for a significant industry share. The United States, in particular, benefits from well-established reimbursement policies, high per-capita healthcare spending, and advanced medical infrastructure. These factors have solidified North America’s leading market position and fostered strong business growth in neurosurgical radiosurgery. Canada’s growing oncology centers and expanding federal support for cancer treatment have further bolstered the region’s market size.
Fastest Growing Region for Gamma Knife Market
Asia-Pacific is poised to be the fastest growing region for the Gamma Knife market over the forecast period. Rapidly expanding healthcare infrastructure in China and India is a primary market driver, as governments channel resources into radiotherapy and neurosurgery capabilities. Rising cancer incidence, coupled with improving access to advanced treatment centers, is fueling strong demand. In addition, market opportunities in South Korea and Singapore stem from high public awareness of cancer screening and next-generation treatment adoption.
Get more insights on, Gamma Knife Market
Get This Report in Japanese Language: ガンマナイフ市場
Get This Report in Korean Language: 감마 나이프 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)